ANI PHARMACEUTICALS INC (ANIP) › Cost of RevenueANI PHARMACEUTICALS INC (ANIP) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2012: $9.17M2013: $9.97M2014: $11.47M2015: $12.69M2016: $48.78M2017: $79.03M2018: $73.02M2019: $63.15M2020: $87.16M$87.16M2012Cost of Revenue (USD)2020Fiscal YearCost of RevenueChange YoY2020$87.16M+38.0%2019$63.15M-13.5%2018$73.02M-7.6%2017$79.03M+62.0%2016$48.78M+284.3%2015$12.69M+10.6%2014$11.47M+15.0%2013$9.97M+8.8%2012$9.17M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share